Cytogen Inc (217330) - Total Liabilities

Latest as of December 2025: ₩26.25 Billion KRW ≈ $17.79 Million USD

Based on the latest financial reports, Cytogen Inc (217330) has total liabilities worth ₩26.25 Billion KRW (≈ $17.79 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Cytogen Inc to assess how effectively this company generates cash.

Cytogen Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Cytogen Inc's total liabilities have evolved over time, based on quarterly financial data. Check 217330 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Cytogen Inc Competitors by Total Liabilities

The table below lists competitors of Cytogen Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Intech Biopharm Ltd TWO:6461	Taiwan	NT$1.51 Billion
Y-Entec Co. Ltd KQ:067900	Korea	₩152.37 Billion
Hainan Airlines Co Ltd B SHG:900945	China	$140.66 Billion
Raisio Oyj HE:RAIKV	Finland	€64.30 Million
EPE Capital Partners Ltd JSE:EPE	South Africa	ZAC201.00 Million
Lion Selection Group Ltd AU:LSX	Australia	AU$11.45 Million
Cameo Communications Inc TW:6142	Taiwan	NT$1.20 Billion
ÖKOWORLD AG XETRA:VVV3	Germany	€24.57 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Cytogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cytogen Inc (217330) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.74	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cytogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cytogen Inc (2014–2025)

The table below shows the annual total liabilities of Cytogen Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩26.25 Billion ≈ $17.79 Million	+9.85%
2024-12-31	₩23.89 Billion ≈ $16.19 Million	+13.27%
2023-12-31	₩21.09 Billion ≈ $14.30 Million	-40.69%
2022-12-31	₩35.56 Billion ≈ $24.10 Million	+9.36%
2021-12-31	₩32.52 Billion ≈ $22.04 Million	+226.05%
2020-12-31	₩9.97 Billion ≈ $6.76 Million	+455.30%
2019-12-31	₩1.80 Billion ≈ $1.22 Million	+152.43%
2018-12-31	₩711.51 Million ≈ $482.18K	-24.91%
2017-12-31	₩947.50 Million ≈ $642.11K	-79.34%
2016-12-31	₩4.59 Billion ≈ $3.11 Million	+187.30%
2015-12-31	₩1.60 Billion ≈ $1.08 Million	+1.68%
2014-12-31	₩1.57 Billion ≈ $1.06 Million	--

About Cytogen Inc

KQ:217330 Korea Diagnostics & Research

Market Cap

$92.24 Million

₩136.11 Billion KRW

Market Cap Rank

#19486 Global

#1083 in Korea

Share Price

₩5900.00

Change (1 day)

+2.97%

52-Week Range

₩2320.00 - ₩9420.00

All Time High

₩22599.98